$2.77B
$54,000
0.0% of portfolio
1,606
Q3 2025
Reduced 95.6%
$3.26B
$59,000
0.0% of portfolio
500
Q3 2025
Reduced 50.0%
$7.49B
$1.23 Million
0.0% of portfolio
3,100
Q3 2025
Reduced 3.13%
$4B
$47,000
0.0% of portfolio
598
Q3 2025
Reduced 96.89%
$15.3B
$331,000
0.0% of portfolio
1,857
Q3 2025
Reduced 86.8%
$12.4B
$294,000
0.0% of portfolio
1,807
Q2 2025
New
$495M
$347,000
0.0% of portfolio
121,200
Q2 2025
Added 7.64%
$23.2B
$320,000
0.0% of portfolio
3,783
Q3 2025
Reduced 87.78%
$5.92B
$62,000
0.0% of portfolio
2,535
Q3 2025
Added 1.2%
$244M
$590,000
0.0% of portfolio
102,700
Q3 2025
New
$1.88B
$877,000
0.0% of portfolio
15,900
Q3 2025
New
$3.16B
$1.09 Million
0.0% of portfolio
9,600
Q3 2025
Added 12.94%
$1.84B
$7,000
0.0% of portfolio
100
Q3 2025
Reduced 98.65%
$622M
$647,000
0.0% of portfolio
16,900
Q3 2025
Added 3.05%
$158M
$13,000
0.0% of portfolio
1,700
Q3 2025
Reduced 87.02%
$7.2B
$567,000
0.0% of portfolio
2,300
Q3 2025
Added 27.78%
$1.35B
$267,000
0.0% of portfolio
5,000
Q3 2025
Reduced 5.66%
$656M
$322,000
0.0% of portfolio
62,500
Q3 2024
Reduced 5.59%
$572M
$444,000
0.0% of portfolio
31,800
Q3 2025
New
$202M
$544,000
0.0% of portfolio
20,300
Q3 2025
Added 86.24%
$2.3B
$134,000
0.0% of portfolio
1,300
Q3 2025
Reduced 50.0%
$2.71B
$785,000
0.0% of portfolio
19,200
Q2 2025
Added 10.34%
$233M
$556,000
0.0% of portfolio
24,200
Q3 2025
Reduced 6.92%
$357M
$327,000
0.0% of portfolio
10,700
Q2 2025
New
$1.9B
$406,000
0.0% of portfolio
14,200
Q3 2025
Reduced 2.74%
$251M
$93,000
0.0% of portfolio
12,400
Q2 2025
Added 19.23%
$1.06B
$626,000
0.0% of portfolio
8,800
Q3 2025
Reduced 5.38%
$2.04B
$38,000
0.0% of portfolio
2,226
Q3 2025
Reduced 1.85%
$481M
$100,000
0.0% of portfolio
76,600
Q3 2024
Reduced 5.43%
Perspective Therapeutics Inc
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 39.08%
-
$0
0.0% of portfolio
-
Q1 2025
New
$642M
$350,000
0.0% of portfolio
10,800
Q3 2025
New
$2.05B
$251,000
0.0% of portfolio
11,300
Q3 2025
Reduced 18.71%
$8.02B
$789,000
0.0% of portfolio
7,800
Q3 2025
Reduced 1.27%
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 84.16%
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 65.76%
$868M
$745,000
0.0% of portfolio
75,500
Q3 2025
New
-
$0
0.0% of portfolio
-
Q3 2025
New
$172M
$255,000
0.0% of portfolio
52,100
Q2 2025
Added 7.64%
$278M
$31,000
0.0% of portfolio
1,600
Q1 2024
Reduced 5.88%
$118M
$0
0.0% of portfolio
100
Q4 2024
Added 2,700.0%
$1.43B
$746,000
0.0% of portfolio
19,600
Q3 2025
Reduced 2.49%
$2.97B
$1.07 Million
0.0% of portfolio
37,100
Q3 2025
Reduced 7.48%
$5.77B
$145,000
0.0% of portfolio
3,072
Q3 2025
Added 0.07%
$574M
$102,000
0.0% of portfolio
11,400
Q1 2024
Reduced 5.79%
$2.97B
$119,000
0.0% of portfolio
400
Q3 2025
Reduced 33.33%
$440M
$589,000
0.0% of portfolio
89,800
Q3 2025
Added 5.52%
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 55.4%
$32B
$719,000
0.0% of portfolio
4,114
Q3 2025
Reduced 71.25%
$700M
$621,000
0.0% of portfolio
20,800
Q3 2025
Reduced 27.78%